Putting in place a patient-centric marketing approach might prove a good strategy for a pharma company. Patient groups and patients are invited to the table to debate regulatory issues, political policy issues and in some cases reimbursement issues as well. This article summarizes two presentations made at the eyeforpharma Barcelona 2013 conference.
This article reviews several recent industry surveys and one new survey proposed by the FDA. The review provides a glimpse into how physicians perceive direct-to-consumer (DTC) advertising, which physicians use social networking the most in their professional lives, and why physicians may be growing cool toward ePromotion even as pharma steps up it ePromotion spending.
Welcome to Volume 12, Issue #5 (20 May 2013) of Pharma Marketing News.
Welcome to Volume 12, Issue #4 (17 April 2013) of Pharma Marketing News.
This article is a review of an interview of Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. It covers the prospects for FDA's final guidance on regulation of MMAs and other regulatory issues that the mobile health community and FDA will likely face after publication of the 'final' guidelines.
A conversation with Angel Gonzalez, Founder & CEO, Ideagoras, and Veronica Botet, Global Manager, Digital and Social Media, GE Healthcare. The discussion focuses on the #GetFit initiative, a worldwide competition and social media campaign designed to raise public awareness about cancer prevention.
Vivacare offers industry partners (pharmaceutical firms, device firms and/or their agencies) an opportunity to develop and distribute 'Disease Education Kits' that leverage Vivacare's patient education platform and physician network. This article is a review of Vivacare's service as part of a pharmaceutical brand's digital marketing efforts.
This article summarizes the results of the online 'Rate Your Social Media Marketing Readiness' self-assessment tool/survey and compares results from two different time periods to determine if any progress has been made in overcoming the risks faced by pharma in using social media.
Welcome to Volume 12, Issue #3 (18 March 2013) of Pharma Marketing News.